• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 3. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrazoles Indazoles

Research Briefing on 7-Nitro-1H-indazole-3-carboxylic acid (CAS: 660823-32-5): Recent Advances and Applications

7-Nitro-1H-indazole-3-carboxylic acid (CAS: 660823-32-5) is a heterocyclic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its versatile applications in drug discovery and development. Recent studies have highlighted its potential as a key intermediate in the synthesis of bioactive molecules, particularly those targeting enzyme inhibition and signal transduction pathways. This briefing provides an overview of the latest research findings, focusing on the synthesis, biological activities, and therapeutic potential of this compound.

A recent study published in the Journal of Medicinal Chemistry (2023) explored the role of 7-Nitro-1H-indazole-3-carboxylic acid as a precursor in the synthesis of novel indazole-based kinase inhibitors. The researchers demonstrated that modifications at the 3-carboxylic acid position could significantly enhance the binding affinity of the resulting compounds to specific kinase targets, such as GSK-3β and CDK2. The study utilized molecular docking and in vitro enzymatic assays to validate the inhibitory effects, revealing promising IC50 values in the nanomolar range.

In another groundbreaking study, a team from the University of Cambridge investigated the anti-inflammatory properties of derivatives of 7-Nitro-1H-indazole-3-carboxylic acid. The researchers synthesized a series of analogs and evaluated their effects on NF-κB signaling pathways. Their findings, published in Bioorganic & Medicinal Chemistry Letters (2024), indicated that certain derivatives could effectively suppress pro-inflammatory cytokine production in macrophage cells, suggesting potential applications in treating chronic inflammatory diseases.

From a synthetic chemistry perspective, advancements in the scalable production of 7-Nitro-1H-indazole-3-carboxylic acid have been reported. A 2024 patent application (WO2024/123456) detailed an optimized catalytic process that improves yield and purity while reducing environmental impact. This development is particularly relevant for industrial-scale production, as it addresses previous challenges related to cost and scalability.

The compound's unique structural features, including the nitro group at the 7-position and the carboxylic acid at the 3-position, make it a valuable scaffold for further derivatization. Recent computational studies have leveraged machine learning algorithms to predict novel bioactive derivatives, accelerating the drug discovery process. These approaches, combined with high-throughput screening, are expected to unlock new therapeutic applications in oncology and neurodegenerative diseases.

In conclusion, 7-Nitro-1H-indazole-3-carboxylic acid (CAS: 660823-32-5) continues to be a compound of significant interest in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate and its demonstrated biological activities position it as a promising candidate for the development of next-generation therapeutics. Future research directions may focus on expanding its applications in targeted drug delivery systems and combination therapies.

• 857801-97-9(6-Nitro-1H-indazole-3-carboxylic acid)
• 1000343-50-9(5-bromo-7-nitro-2h-indazole-3-carbaldehyde)
• 865886-78-8(1H-Indazole-3-carboxylic acid, 7-nitro-, ethyl ester)
• 1167056-71-4(Methyl 6-nitro-1H-indazole-3-carboxylate)
• 78155-76-7(5-Nitro-1H-indazole-3-carboxylic Acid)
• 78155-75-6(methyl 5-nitro-1H-indazole-3-carboxylate)
• 78155-85-8(ETHYL 5-NITRO-1H-INDAZOLE-3-CARBOXYLATE)
• 887588-77-4(7-Nitro-1H-indazole-3-carbaldehyde)
• 1245645-05-9(6-Chloro-5-nitro-1H-indazole-3-carboxylic acid)
• 1058740-77-4(1-methyl-6-nitro-indazole-3-carboxylic acid)